FOXA1 and breast carcinoma: Our methodology is validated by some TTAGPs relevant to EC that had previously been confirmed by other authors, for example; FOXA1 was also a highly upregulated DEG, which is known to regulate oestrogen receptor binding in breast cancer [69].